Literature DB >> 837339

Lymphatic metastasis with childhood rhabdomyosarcoma.

W Lawrence, D M Hays, T E Moon.   

Abstract

Clinico-pathologic reviews of series of children with rhabdomyosarcoma have yielded conflicting information regarding frequency of lymphatic spread of this disease. The 264 eligible entries in the Intergroup Rhabdomyosarcoma Study (from November 1972 to September 1975) have been categorized by a prospective staging system and pre-treatment characteristics and pathologic findings reviewed. Data accumulated thus far have revealed a higher than expected incidence of lymphatic metastases from extremity (17%) and genito-urinary sites (19%) with a somewhat lower incidence from the orbit (0%), the head and neck region (3%), and trunk (10%). These differences in regard to lymphatic metastases were found to have no relationship to age, sex, tumor size, or histologic type when these factors were simultaneously examined.

Entities:  

Mesh:

Year:  1977        PMID: 837339     DOI: 10.1002/1097-0142(197702)39:2<556::aid-cncr2820390226>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  The management of rhabdomyosarcoma in children and young adults.

Authors:  D M Hays
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

2.  Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients.

Authors:  Y Fong; D G Coit; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

3.  Rhabdomyosarcoma of parotid gland.

Authors:  A Goel; S C Gupta; S C Gupta; D N Awasthi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1997-10

Review 4.  The role of radiology in paediatric soft tissue sarcomas.

Authors:  K Park; R van Rijn; K McHugh
Journal:  Cancer Imaging       Date:  2008-04-22       Impact factor: 3.909

5.  Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group.

Authors:  J E Kingston; T J McElwain; J S Malpas
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.